C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
---|
ABS | ESOT | | | DRUG 2018-1 (USD 100m) | DRI Capital Inc | | USOA | Nov 30, 2018 | | Class | CCY | SIZE (M) | WAL | MO | SP | FI | DR | KR | C/E | LTV | TYPE | BNCH | IPT | GDNC | SPRD | CPN | YLD | PRICE |
---|
D2 | EAY | 22.000 | 7.86 | - | EEE | - | - | FFF | - | - | - | - | - | - | - | 4.27% | 4.300% | 68.28146 | J1 | UTW | 70.000 | 3.63 | - | CCC | - | - | PPP | - | - | Ieswelob | 3wS | - | - | 160 | 3sL+160 | - | 232.00000 |
Tranche Comments J1: Registration: 144E Rmra;
D2: Registration: 144H Swjw; |
|
|
|
|
|
|